GO:0002513 tolerance induction to self antigen: Immune Tolerance Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002513 (tolerance induction to self antigen) is the biological process by which the immune system establishes non-responsiveness specifically directed at the body's own antigens.
• Central tolerance occurs mainly in the thymus, where antigen presentation shapes the deletion of self-reactive T cells and the generation of regulatory T cells.
• Alternative splicing of thymic self-antigen transcripts broadens the self-antigen repertoire and helps suppress autoimmunity.
• Peripheral tolerance mechanisms, including oral tolerance and intestinal cross-tolerance, reinforce self-antigen non-responsiveness outside the thymus.
• Antigen-specific tolerance induction is being developed as a therapy for multiple sclerosis, type 1 diabetes and other T cell mediated diseases.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal testing of genes that control self-antigen tolerance.
Description
Tolerance induction to self antigen (GO:0002513) is the immunological process that prevents the immune system from attacking the body's own tissues. It is a fundamental biological_process that ensures self/non-self discrimination and protects against autoimmunity. The term encompasses both central tolerance, which is established during lymphocyte development, and peripheral tolerance, which is maintained in the circulation and tissues. Understanding this process is essential because its failure underlies many autoimmune diseases, and its deliberate induction is a major goal of antigen-specific immunotherapy.
tolerance induction to self antigen At A Glance
| GO ID | GO:0002513 |
|---|---|
| GO term | tolerance induction to self antigen |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Establishment of immunological non-responsiveness specifically directed at self antigens |
| Related processes | Central tolerance, peripheral tolerance, regulatory T cell induction, oral tolerance |
| Key anatomical sites | Thymus, secondary lymphoid organs, intestinal mucosa |
| Therapeutic relevance | Antigen-specific tolerance induction for autoimmune and inflammatory diseases |
What Is GO:0002513?
According to the Gene Ontology, tolerance induction to self antigen (GO:0002513) is defined as tolerance induction directed at self antigens. In other words, it is the set of immunological mechanisms that specifically establish and maintain unresponsiveness to the body's own antigenic components, as opposed to tolerance to foreign or environmental antigens.
Why Is tolerance induction to self antigen Important in Cell Biology?
Tolerance induction to self antigen is important because it is the primary safeguard against autoimmunity, and its manipulation offers a route to treat diseases caused by unwanted immune responses without broad immunosuppression. Defects in central tolerance mechanisms, such as impaired thymic antigen presentation or altered self-antigen splicing, can permit self-reactive lymphocytes to escape and drive autoimmunity. Conversely, harnessing peripheral tolerance pathways, including oral tolerance and intestinal cross-tolerance, provides antigen-specific strategies for restoring immune balance.
• Prevents autoimmunity by eliminating or controlling self-reactive T and B lymphocytes.
• Central tolerance in the thymus depends on antigen presentation of self-peptides to developing T cells.
• Alternative splicing of thymic self-antigen transcripts expands the self-antigen repertoire and suppresses autoimmunity.
• Peripheral tolerance mechanisms reinforce self-antigen non-responsiveness in tissues.
• Oral tolerance is a clinically relevant route for inducing antigen-specific tolerance.
• Intestinal cDC1 can drive cross-tolerance to epithelial-derived antigens via FoxP3+CD8+ Tregs.
• Antigen-specific tolerance induction is being tested in multiple sclerosis models without broad immunosuppression.
• TCR-based antigen-specific therapy for type 1 diabetes aims to edit autoreactive clones and induce tolerance.
• Tolerance induction is a therapeutic goal in T cell mediated diseases.
• CRISPR gene editing enables causal dissection of tolerance-controlling genes.
What Happens During tolerance induction to self antigen?
Central tolerance in the thymus
In simple terms: In the thymus, developing T cells are shown the body's own proteins so that any T cell that reacts strongly to them is removed or converted into a regulatory cell.
Central tolerance is initiated in the thymus, where antigen presentation of self-peptides to developing T cells leads to the deletion of strongly self-reactive thymocytes and the generation of regulatory T cells. This process depends on the display of a broad repertoire of self-antigens by thymic antigen-presenting cells.
Splicing control of the thymic self-antigen repertoire
In simple terms: The thymus uses alternative splicing to make many different versions of self-proteins, which helps it test T cells against a wider set of self-antigens.
Transcript splicing optimizes the thymic self-antigen repertoire to suppress autoimmunity, meaning that regulated splicing of self-antigen transcripts broadens the range of self-peptides presented in the thymus and thereby strengthens central tolerance.
Peripheral tolerance and oral tolerance
In simple terms: Outside the thymus, the immune system can also learn to ignore self-antigens, for example when antigens are encountered through the gut.
Peripheral tolerance mechanisms maintain non-responsiveness to self-antigens after lymphocytes leave the thymus. Oral tolerance is a form of peripheral tolerance induced by antigen exposure via the oral route, and it is studied as a means of inducing antigen-specific tolerance.
Intestinal cross-tolerance via cDC1 and regulatory T cells
In simple terms: Special immune cells in the intestine can teach the immune system to tolerate proteins from the body's own epithelial lining.
Intestinal cDC1 drive cross-tolerance to epithelial-derived antigen via induction of FoxP3+CD8+ Tregs, demonstrating a peripheral mechanism by which self-antigens from epithelial tissues are tolerated.
Antigen-specific tolerance induction as therapy
In simple terms: Scientists are developing ways to deliberately turn off immune reactions against specific self-antigens to treat autoimmune diseases.
Antigen-specific tolerance induction is being pursued in multiple sclerosis models without broad immunosuppression, in type 1 diabetes through TCR-based antigen-specific therapy, and more generally in T cell mediated diseases.
Key Genes Involved in GO:0002513 tolerance induction to self antigen
The following genes and proteins are central to the induction and maintenance of tolerance to self antigens.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FOXP3 | Master transcription factor for regulatory T cells | Central to peripheral tolerance and Treg-mediated suppression |
| AIRE | Promotes expression of tissue-restricted self-antigens in the thymus | Key regulator of central tolerance |
| HLA-DQ | Presents self-peptides to developing T cells | Antigen presentation for central tolerance |
| HLA-DR | Presents self-peptides to developing T cells | Antigen presentation for central tolerance |
| CD8A | Coreceptor on CD8+ T cells and FoxP3+CD8+ Tregs | Intestinal cross-tolerance to epithelial antigen |
| ITGAX | Marker of cDC1 dendritic cells | Drives cross-tolerance in the intestine |
| BATF3 | Transcription factor required for cDC1 development | Required for intestinal cDC1-mediated tolerance |
| IL2RA | IL-2 receptor alpha chain (CD25) | Supports regulatory T cell survival and tolerance |
| TGFB1 | Immunosuppressive cytokine | Promotes tolerance induction |
| IL2 | T cell growth factor with tolerogenic roles | IL-2-TGFβ surrogate agonist induces tolerance |
| TCR | T cell receptor recognizing self-peptides | TCR-based antigen-specific therapy for type 1 diabetes |
| INS | Self-antigen in type 1 diabetes | Target of antigen-specific tolerance induction |
| MBP | Self-antigen in multiple sclerosis models | Target of antigen-specific tolerance |
| MOG | Self-antigen in multiple sclerosis models | Target of antigen-specific tolerance |
| PLP1 | Self-antigen in multiple sclerosis models | Target of antigen-specific tolerance |
| GAD1 | Self-antigen in type 1 diabetes | Target of antigen-specific tolerance |
| GAD2 | Self-antigen in type 1 diabetes | Target of antigen-specific tolerance |
How Is tolerance induction to self antigen Regulated?
Tolerance induction to self antigen is regulated at multiple levels. In the thymus, antigen presentation and transcript splicing control the self-antigen repertoire available for negative selection and Treg generation. In the periphery, cytokines such as IL-2 and TGFβ regulate the induction and maintenance of tolerance, as shown by an IL-2-TGFβ surrogate agonist that facilitates immune tolerance. Oral tolerance is regulated by the dose, route and timing of antigen exposure. Intestinal cDC1 and FoxP3+CD8+ Tregs provide a regulated pathway for cross-tolerance to epithelial-derived self-antigens.
tolerance induction to self antigen and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FOXP3 | Autoimmunity due to regulatory T cell dysfunction | Foxp3 knockout mouse, Treg-specific knock-in reporters |
| AIRE | Autoimmune polyendocrinopathy | Aire knockout mouse for central tolerance studies |
| INS | Type 1 diabetes | Antigen-specific tolerance induction in NOD mice |
| MBP | Multiple sclerosis | EAE model with antigen-specific tolerance |
| TGFB1 | Immune dysregulation | IL-2-TGFβ surrogate agonist treatment models |
Autoimmune diseases
Failure of tolerance induction to self antigen is a central mechanism in autoimmune diseases such as multiple sclerosis and type 1 diabetes. Antigen-specific tolerance induction strategies are being developed to restore non-responsiveness to self-antigens without broad immunosuppression.
Type 1 diabetes
In type 1 diabetes, autoreactive T cell clones escape tolerance and destroy pancreatic beta cells. TCR-based antigen-specific therapy aims to edit autoreactive clones and induce tolerance to self-antigens such as insulin and GAD.
Multiple sclerosis
Multiple sclerosis is associated with loss of tolerance to myelin self-antigens. Induction of antigen-specific tolerance in a multiple sclerosis model has been achieved without broad immunosuppression, highlighting the therapeutic potential of targeting this process.
Intestinal inflammation
Intestinal cDC1-driven cross-tolerance to epithelial-derived antigen via FoxP3+CD8+ Tregs is relevant to maintaining immune homeostasis in the gut, and its disruption may contribute to inflammatory conditions.
From tolerance induction to self antigen-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X control central tolerance? | Knockout mouse or CRISPR knockout in thymic epithelial cells |
| Does a point mutation in gene X alter self-antigen presentation? | Point-mutation knock-in cell model |
| Can a self-antigen be tagged to track tolerance induction? | Tagged knock-in of the self-antigen locus |
| Does overexpression of gene X break tolerance? | Overexpression cell model or transgenic mouse |
| Can antigen-specific tolerance be induced therapeutically? | Antigen-specific tolerance induction in autoimmune models |
| What is the role of intestinal cDC1 in cross-tolerance? | Intestinal cDC1 knockout or Batf3-deficient models |
How to Study the tolerance induction to self antigen Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Frequency and phenotype of self-antigen-specific T cells | Monitoring tolerance induction |
| Single-cell RNA-seq | Transcriptional states of immune cells | Dissecting tolerance mechanisms |
| CRISPR knockout screening | Genes required for tolerance | Discovery of tolerance regulators |
| Tetramer staining | Antigen-specific T cell populations | Detecting autoreactive clones |
| EAE model | Autoimmune demyelination | Testing tolerance-inducing therapies |
| NOD mouse model | Spontaneous type 1 diabetes | Antigen-specific tolerance for diabetes |
| Oral tolerance assay | Systemic unresponsiveness after oral antigen | Studying peripheral tolerance |
Flow cytometry and tetramer staining
Flow cytometry with peptide-MHC tetramers allows detection and quantification of self-antigen-specific T cells, which is essential for measuring tolerance induction.
Single-cell RNA sequencing
Single-cell RNA sequencing can profile thymic and peripheral immune cell populations to identify transcriptional programs associated with tolerance induction to self antigen.
CRISPR screens
CRISPR library screening enables unbiased discovery of genes that regulate tolerance induction, including those controlling antigen presentation and regulatory T cell function.
Autoimmune disease models
Experimental autoimmune encephalomyelitis (EAE) and non-obese diabetic (NOD) mouse models are used to test antigen-specific tolerance induction strategies.
How CRISPR Can Be Used to Study GO:0002513 tolerance induction to self antigen
Knockout
CRISPR knockout of candidate genes such as Foxp3, Aire or Batf3 in cell models or mice can reveal their requirement for tolerance induction to self antigen.
Point Mutation
Point mutations introduced by CRISPR base editing or HDR can model disease-associated variants in genes that control self-antigen presentation or regulatory T cell function.
Knock-in
Knock-in of tagged self-antigens or reporter alleles allows tracking of antigen expression and tolerance induction in vivo.
Overexpression
Overexpression of tolerance-related genes or self-antigens can be used to test whether increased antigen levels break or reinforce tolerance.
How EDITGENE Supports tolerance induction to self antigen Research
Researchers studying tolerance induction to self antigen-related genes often need to determine whether a candidate gene is causally involved in establishing or breaking self-tolerance. EDITGENE provides the CRISPR tools and services to build precisely engineered cell and animal models for such causal experiments.
Contact EDITGENE today to design your custom CRISPR model for tolerance induction to self antigen research.
Frequently Asked Questions About tolerance induction to self antigen
What is tolerance induction to self antigen?
Tolerance induction to self antigen (GO:0002513) is the biological process by which the immune system establishes non-responsiveness specifically directed at the body's own antigens.
What genes are involved in tolerance induction to self antigen?
Key genes include FOXP3, AIRE, HLA-DQ, HLA-DR, CD8A, ITGAX, BATF3, IL2RA, TGFB1 and IL2, among others.
Where does tolerance induction to self antigen occur?
It occurs mainly in the thymus for central tolerance and in secondary lymphoid organs and tissues for peripheral tolerance.
How is tolerance induction to self antigen studied?
It is studied using flow cytometry, tetramer staining, single-cell RNA sequencing, CRISPR screens and autoimmune disease models such as EAE and NOD mice.
What happens when tolerance induction to self antigen fails?
Failure leads to autoimmunity, including multiple sclerosis and type 1 diabetes, as self-reactive lymphocytes attack the body's own tissues.
Can tolerance induction to self antigen be used therapeutically?
Yes, antigen-specific tolerance induction is being developed as a therapy for multiple sclerosis, type 1 diabetes and other T cell mediated diseases.
What is the role of the thymus in tolerance induction to self antigen?
The thymus presents self-antigens to developing T cells, leading to deletion of strongly self-reactive cells and generation of regulatory T cells.
How does alternative splicing affect tolerance induction to self antigen?
Alternative splicing of thymic self-antigen transcripts broadens the self-antigen repertoire and helps suppress autoimmunity.
What is oral tolerance?
Oral tolerance is a form of peripheral tolerance induced by antigen exposure via the oral route, and it is studied for antigen-specific tolerance induction.
What CRISPR models are used to study tolerance induction to self antigen?
Knockout, point mutation, knock-in and overexpression models are used to test the causal role of genes in tolerance induction.
Conclusion
Tolerance induction to self antigen (GO:0002513) is a central biological process that protects against autoimmunity through central and peripheral mechanisms. Its molecular control involves antigen presentation, transcript splicing, regulatory T cells and cytokines such as IL-2 and TGFβ. Understanding and manipulating this process offers promising therapeutic avenues for autoimmune diseases, and CRISPR-based models are powerful tools for dissecting the underlying genes.
References
- 1. Klein L et al.. 2025. Antigen presentation for central tolerance induction.. Nat Rev Immunol 25(1):57-72 PMID: 39294277
- 2. Muro R et al.. 2024. Transcript splicing optimizes the thymic self-antigen repertoire to suppress autoimmunity.. J Clin Invest 134(20) PMID: 39403924
- 3. Sun Q et al.. 2026. Facile induction of immune tolerance by an interleukin-2-TGFβ surrogate agonist.. Nature 653(8115):888-899 PMID: 41813890
- 4. Weiner HL et al.. 2011. Oral tolerance.. Immunol Rev 241(1):241-59 PMID: 21488901
- 5. Joeris T et al.. 2021. Intestinal cDC1 drive cross-tolerance to epithelial-derived antigen via induction of FoxP3(+)CD8(+) T(regs).. Sci Immunol 6(60) PMID: 34088744
- 6. Stiepel RT et al.. 2025. Induction of Antigen-Specific Tolerance in a Multiple Sclerosis Model without Broad Immunosuppression.. ACS Nano 19(3):3764-3780 PMID: 39812522
- 7. Fisher M et al.. 2025. TCR-Based Antigen-Specific Therapy for Type 1 Diabetes Mellitus: From Editing Autoreactive Clones to Tolerance Induction.. Int J Mol Sci 26(23) PMID: 41373714
- 8. Passerini L et al.. 2020. Induction of Antigen-Specific Tolerance in T Cell Mediated Diseases.. Front Immunol 11:2194 PMID: 33133064
